Y

Ysios Capital

19 employees

Ysios Capital is a leading life sciences investor financing highly innovative companies worldwide

Investor insights

Sectors invested in

Biotechnology49
Health Care47
Medical26
Pharmaceutical19
Medical Device15
Therapeutics13
Health Diagnostics10
Biopharma8
Life Science7
Genetics5
biotechnology5
Hospital4
Biotech4
Clinical study4
AKI4
recAP4
Sepsis4
research4
drug development4
nanotechnology4

Funding rounds participated in

$35M sweet spot round size

Most of their 65 investments are in rounds between $20M and $53M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Venture capital and biotechnology
Financial Services
Finance
Asset Management

Date founded

2008

Investments made

X

Xeltis raised $14M on August 14, 2023

Investors: EQT Life Sciences, DaVita Venture Group, VI Partners AG, Grand Patika and Ysios Capital

T

Tagworks Pharmaceuticals raised $65M on June 22, 2023

Investors: Meneldor, Gilde Healthcare, Lightstone Ventures, Oost NL and Ysios Capital

U

Undisclosed raised $37M on May 25, 2023

Investors: Libertatis Ergo Holding B.V., Lundbeckfonden / Lundbeck Foundation, Wake Forest Innovation Quarter, Sound Bioventures, BGV (BioGeneration Ventures) and Ysios Capital

A

Adcendo raised $34M on April 4, 2023

Investors: Gilde Healthcare, HealthCap, RA Capital Management, L.P., Pontifax Venture Capital, Novo Holdings and Ysios Capital

S

SparingVision raised $75M on September 14, 2022

Investors: RD Fund, UPMC Enterprises, JEITO and Ysios Capital

M

Mineralys Therapeutics, Inc. raised $118M on June 8, 2022

Investors: Sectoral Asset Management, HEALTHCOR LTD, Samsara BioCapital, Catalys Pacific, S.R. One Ltd, RA Capital Management, L.P., RTW Investments, LP and Ysios Capital

M

Minoryx Therapeutics raised $55M on May 31, 2022

Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., FundPlus, CDTI, Centre for the Development of Industrial Technology and Ysios Capital

P

ProteoDesign raised $57M on February 15, 2022

Investors: UCB Ventures, Gilde Healthcare, Asabys Partners and Ysios Capital

N

North Sea group raised $80M on December 17, 2021

Investors: -, Hercules Capital, Inc., BGV (BioGeneration Ventures), Forbion, venBio Partners, Sofinnova Ventures, Russia technology fund and Ysios Capital

A

Aura Biosciences raised undisclosed on November 3, 2021

Investors: Ysios Capital

FAQ